Delivery Order SPE2DB22D1106-SPE2DB25FEWE6
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, to provide 4,565,265,370 units of Mycophenolate 200 mg/ml suspension, a critical pharmaceutical product. The contract has a total ceiling value of $1,271.31 and an ultimate completion date of July 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen has been awarded numerous federal contracts by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,777.14, is for the supply of Mycophenolate 500 mg tablets. The contract is not set aside and was competitively awarded. It has a performance period extending to June 18, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a $10,782.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MYCOPHENOLATE 500 MG TABLET 500S. The contract has an ultimate completion date of June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide 160 ml bottles of Mycophenolate 200 mg/ml suspension. The $3,561.92 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order. No set-aside designation was used. Amerisourcebergen Drug...
This is a $1,876.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for MYCOPHENOLATE 500 MG TABLET 500S, a prescription medication, with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 100S, a medical product, with a firm fixed price of $1,836.90 and a completion date of June 10, 2025. The contract is not set aside and was awarded on June 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mycophenolate 500 mg tablets. The contract is a firm fixed-price, non-set-aside arrangement with a ceiling value of $10,893.69 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price for the supply of 500-milligram Mycophenolate tablets. The award has a ceiling value of $3,005.76 and a completion date of June 9, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen holds a substantial Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Mycophenolate 500 mg tablets, with a potential value of $1,185.72 and a completion date of December 26, 2023. The contract is not set aside for any particular business type. As a prime contractor, AmerisourceBergen Drug Corporation has a history of providing pharmaceutical products and...
This is a $2,254.08 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of MYCOPHENOLATE 100S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided about major subcontractors. The contract supports the DLA's role in providing medical supplies and pharmaceuticals to...